Chromium Supplement Awarded U.S. Patent for Lowering Cholesterol
(retyped for clarity)

        The U.S. Patent Office has approved a patent on the
cholesterol lowering effects of a unique chromium-niacin compound
called Chromate.  U.S. patent No. 4,954,492 is the first and only
patent awarded a chromium supplement for lowering blood lipids such
as cholesterol and triglycerides.
        Chromate,  manufactured by InterHealth of Concord,  Calif.,  
has been shown to lower cholesterol and triglycerides levels in
test animals and in humans.  A University study awaiting
publication,  involving 34 subjects showed Chromate substantially
lowered serum cholesterol levels,  improved total cholesterol/HDL
ratios and reduced triglycerides levels in young male athletes who
had moderate cholesterol levels to begin with.
        The study was directed by Robert Lafavi,  now Director of
Research for the Health and Human Performance Laboratory at Georgia
Southern University.
        Although Lafavi stresses that the data are preliminary,   he
is very encouraged by the results.  “The results were substantial.”
 Lefavi says,  “What effect this compound will have on people with
high cholesterol levels due to negative chromium balance,  one can
only speculate.”
        Lafavi plans on expanding his research  of the compound by
evaluating its effects on people who are likely to be at risk of
Cardiovascular disease.

dreamd…@gnn.com